Search clinical trials for: sapacitabine

Total 1842 results

Taipei Veterans General Hospital, Taiwan

Unknown

Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer

Gastric Cancer

Taiwan
Royal Marsden NHS Foundation Trust

Completed

Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus

Oesophageal Carcinoma

United Kingdom
Samsung Medical Center

Recruiting

Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer

Biliary Tract Cancer

Korea, Republic of
Zhiyong Yu

Not yet recruiting

Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

Pathologic Residual Cancer Cells

China
Jules Bordet Institute

Completed

Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers (MOMENTUM1)

Metastatic Colorectal Cancers | Metastatic Gastric Cancers | Metastatic Oesophageal Cancers | Metastatic Pancreatic Cancers | Metastatic Biliary Cancers | Metastatic Breast Cancers

Belgium
University of Southern California
Eli Lilly and Company

Completed

Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer

Colorectal Cancer | Colon Cancer

United States
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Sanofi

Terminated

Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery

Pancreatic Neoplasms

United States
Jiangxi Provincial Cancer Hospital

Recruiting

Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Peking Union Medical College Hospital

Recruiting

First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma

Gastrointestinal Neuroendocrine Carcinoma

China
Translational Oncology Research International
Genentech, Inc.

Completed

Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer

Colorectal Cancer

United States
NSABP Foundation Inc
National Cancer Institute (NCI); Cancer and Leukemia Group B

Unknown

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

Colorectal Cancer
Roswell Park Cancer Institute

Completed

Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder

Gallbladder Cancer | Extrahepatic Bile Duct Cancer

United States
Royal Marsden NHS Foundation Trust

Completed

Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma

Adenocarcinoma of Oesophagus

United Kingdom
UNICANCER
Seagen Inc.

Recruiting

Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease (ETIC-LM)

HER2-positive Metastatic Breast Cancer | Leptomeningeal Disease | Leptomeningeal Metastasis

France
National Cancer Centre, Singapore
National Medical Research Council (NMRC), Singapore

Completed

OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma (OXIRI)

Pancreatic Cancer

Singapore
Centre Jean Perrin

Terminated

Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib (ProMETheX)

Colorectal Cancer | Metastatic Breast Cancer

France
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

United States, Canada
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer

Kidney Cancer
Merck Sharp & Dohme LLC

Completed

A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059)

Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma
Hoffmann-La Roche

Completed

A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer

Breast Cancer

Australia, Spain, United Kingdom, France, Sweden, Canada, Finland, Italy, Greece, Mexico, Costa Rica, Poland, Brazil, Guatemala, Panama
Seoul National University Hospital

Completed

Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Korea, Republic of
Ludwig-Maximilians - University of Munich
Sanofi; Merck Sharp & Dohme LLC; Pfizer; Hoffmann-La Roche

Completed

Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.

Metastatic Colorectal Cancer
Fudan University

Recruiting

Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer (BCTOP-T-M01)

Triple-Negative Breast Cancer

China
Second Affiliated Hospital of Guangzhou Medical...

Not yet recruiting

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma
Baptist Health South Florida
Seagen Inc.

Recruiting

Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer

HER2-positive Breast Cancer | Brain Metastases

United States
Beijing Friendship Hospital
Xuanwu Hospital, Beijing; Beijing Chao Yang Hospital; Tianjin Medical University... and other collaborators

Recruiting

Neoadjuvant Chemoradiotherapy Plus Tislelizumab Followed by TME for LARC.

Colorectal Neoplasms

China
Vastra Gotaland Region

Completed

Effect of Low Dose Metronomic Chemotherapy in Metastatic Breast Cancer (METRO)

Chemotherapy Effect | Breast Cancer Metastatic

Sweden
Fudan University

Unknown

Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

Malignant Neoplasm Other Gallbladder/Extrahepatic Bile Duct

China
GlaxoSmithKline

Terminated

Brain Metastases In ErbB2-Positive Breast Cancer

Neoplasms, Breast

United States, Spain, Israel, Canada, Germany, Belgium, Austria, Sweden, Greece, France, Italy
Swiss Group for Clinical Cancer Research

Completed

Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Pain | Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

Switzerland
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Liver Cancer | Extrahepatic Bile Duct Cancer

United States
Swedish Medical Center
Roche Pharma AG

Completed

Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Corporacion Parc Tauli

Not yet recruiting

Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Ttransanal Endoscopic Microsurgery in T1 N0, M0 Rectal Cancer (TAUTEM-T1 Study) (TAUTEM-T1)

Rectal Cancer Stage I
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

DP303c in Patients With HER2-positive Advanced Breast Cancer

HER2-positive Advanced Breast Cancer
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.; Shanghai Junshi Bioscience Co., Ltd.

Recruiting

PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC (Escape)

Esophageal Squamous Cell Carcinoma Abdominal Stage 0

China
Jeroen Bosch Ziekenhuis

Unknown

Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery

Colorectal Cancer

Netherlands
University of California, San Francisco
National Comprehensive Cancer Network

Completed

Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers

Pancreatic Cancer | Biliary Cancer

United States
Kidney Cancer Research Bureau

Completed

Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens

Carcinoma, Renal Cell

Russian Federation
Tongji Hospital

Recruiting

Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

Breast Cancer With Brain Metastases

China
Abramson Cancer Center at Penn Medicine
Roswell Park Cancer Institute; CARTI

Recruiting

CapTemY90 for Grade 2 NET Liver Metastases (CapTemY90)

Neuroendocrine Tumors | Neuroendocrine Tumor Grade 2

United States
PharmaEngine

Terminated

A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer

Rectal Cancer

Taiwan
Array Biopharma, now a wholly owned subsidiary...

Completed

A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer

Advanced Cancer

United States, Canada
The Netherlands Cancer Institute

Completed

Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines

Neoplasms

Netherlands
NYU Langone Health

Completed

Phase II Study for Solid Metastatic Tumors

Breast Cancer | Solid Tumor | Metastatic Breast Cancer
Dutch Colorectal Cancer Group
Sanofi; Hoffmann-La Roche; Koningin Wilhelmina Fonds

Unknown

Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma (CAIRO3)

Colorectal Cancer Metastatic

Netherlands
Cyclacel Pharmaceuticals, Inc.

Completed

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (SEAMLESS)

Acute Myeloid Leukemia

United States, Spain, France, Switzerland, Germany, Italy, Austria, Sweden, Hungary, Belgium, Poland, United Kingdom
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial

Breast Cancer

China
Fudan University

Not yet recruiting

Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)

Breast Cancer

Search clinical trials for: sapacitabine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations